Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated

NCT00869713 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
98
Enrollment
FED
Sponsor class

Conditions

Interventions

Sponsor

U.S. Army Medical Research and Development Command